Ovarian Tumours Max Brinsmead MBBS PhD November 2014.

Slides:



Advertisements
Similar presentations
Dr. Mashael Al-Shebaili Asst. Prof. & Consultant Ob/Gyn Dept.
Advertisements

MALIGNANT OVARIAN TUMOUR
Pt. suffered from chronic intermittent abdominal pain for the last 3-4 months. Over the 24 hours prior to coming into the ER her pain is greatly worsened.
FEMALE GENITAL TRACT II
Max Brinsmead PhD FRANZCOG January 2010
بسم الله الرحمن الرحيم. Pelvic mass Dr.T Allameh MD.
Female Genitalia IV Ovary. l Inflammation l Non-neoplastic cysts l Neoplasms.
Pelvic Masses & Ovarian Cancer. Differential diagnosis of pelvic masses Investigations and management Benign ovarian cysts Ovarian cancer.
Pelvic Pain Mr James Campbell.
SURGICAL APPROACH TO GYNAECOLOGICAL CANCERS
Tim Broadhead Consultant Gynaecologist & Gynaecological Oncologist
Diseases of the ovary Prof. Dr. Noorhan Shakir.
Ovarian Cancer.
Max Brinsmead MB BS PhD May 2015
Abnormal Vaginal Bleeding in a 56 year old Max Brinsmead PhD FRANZCOG May 2015.
OVARY 2 Neoplasms of the Ovary
Ovarian Cystic Masses Atoosa Adibi MD. Department of radiology
Genital cancers and pregnancy Assoc. Prof. Gazi YILDIRIM.
Malignant Ovarian Tumors
Ovary.
Ovarian cancer….. in 15 minutes
UTERINE FIBROIDS Hazem Al-Mandeel, M.D Course 481 Obstetrics and Gynecology Rotation.
Ovarian tumours.
Biomarkers of ovarian cancer and cysts Reproductive Block 1 Lecture By: Reem Sallam, MD, MSc, PhD.
Corpus Lutum Cysts (Ovarian Cysts)
Management of Gynaecological Cancers. Gynaecological Cancers in NSW 1180 new cases in % of all new cancer diagnoses Crude incidence rate 35.3 per.
Ovarian cysts in Primary Care. When to refer? Physiological/pathological Benign/malignant Surgical approach? Open or keyhole? Do I need to do anything?
Management of Adenxal Mass during Pregnancy
Approach to the Patient with a Pelvic Mass Karen Carlson, MD Assistant Professor Department of Obstetrics and Gynecology.
Gynaecological Causes of Acute Pelvic Pain Max Brinsmead MB BS PhD May 2015.
Adult Medical-Surgical Nursing Reproductive Health Module: Ovarian Cyst Polycystic Ovary Syndrome.
Department of pathology Prof:- Adiga. Student name :- Saeed Ayed saed Abdulrahman Awagi Alnami Muhannad Ali Asiri Faris.
Ovarian Cancer May 2007 Dr Anna Winship Guy’s & St. Thomas’ NHS Trust Click Here For First Question Oncology Registrars’ Forum “Best of Five”
Ovarian tumor Wei Jiang, M.D., Ph.D. Attending of Ob & Gyn Ob & Gyn Hospital, Fudan University 419 Fangxie Road, Shanghai -----From.
Fallopian Tube and Ovarian Malignancy Schwartz's Principles of Surgery Chapter 41. Gynecology.
BY DR. KHANSA IQBAL SENIOR REGISTRAR GYNAE UNIT-II.
Ovarian Pathology for Undergraduates Max Brinsmead MB BS PhD November 2014.
Computed tomography scan of the abdomen shows a large cystic mass in the abdomen and pelvis without solid tissue or septations (measurement: 43×20×31-cm.
Hysterectomy for Undergraduates
Chronic Pelvic Pain Max Brinsmead MB BS PhD May 2015.
Management of ovarian cysts
Carcinoma Corpus Uteri
Ovarian cancer Karima salama.
Ovarian Tumors.
Ovarian Tumors By Dr. Ghada Ahmed Lecturer of pathology Benha Faculty of Medicine.
Cancer of the Cervix Max Brinsmead MB BS PhD March 2014.
Dr. Saadeh Jaber OBGYN consultant Epidemiology Second most common gynecological cancer. >35, median 70 It accounts for deaths more than cancer of.
Uterine Fibroids for Undergraduates
Ovarian tumors. *Classification: I. Tumors arising from the surface epithelium:I. Tumors arising from the surface epithelium: Serous tumors: (benign,
Ovarian Cancers In Pregnancy. Incidence Effect on Pregnancy Histologic Variations Clinical Variation Ovarian Cancers in Pregnancy.
Postmenopausal Pelvic mass
Pregnancy related Breast Lesions
Ovarian Cysts Kasey Durham. What are Ovarian Cysts? The Mayo Clinic defines ovarian cysts as fluid filled sacs or pockets located within or on the ovary.
Mark Browning, M.D. IUSME.  22,000 Cases  14,000 Deaths  Overall Survival Rate is 35%  Survival Rate Depends on Stage.
Consultant Obstetrician & Gynaecologist
Biomarkers of ovarian cancer and cysts Reproductive Block 1 Lecture Dr. Usman Ghani.
Metastatic Tumors of Ovary. METASTATIC TUMOR FROM BREAST CANCER both ovaries replaced by pale, rather nodular tumor, with breast cancer cells arranged.
Biomarkers of ovarian cancer and cysts Reproductive Block 1 Lecture Dr. Usman Ghani.
Synchronous Ovarian and Endometrial Carcinomas; An Unusual Outcome of First Trimester Ultrasound Scanning. Karl McPherson, Rhona Lindsay, Jaimie Thiesen-Nash,
BY BY Prof. Mohammad Emam Prof. of OB & GYN. Mansoura Faculty of Medicine EGYPT.
Ovarian cysts and neoplasms in infant , children and adolescents
Benign and Malignant cysts and tumors of the ovary
Ovarian Cancer Screening and Diagnosis
Dr . Saadeh Jaber OBGYN consultant 2010
Screening for Ovarian Cancer
Female Genital Tract د- نجلاء حنون Lec.1
Ovarian Cancer-Route to Diagnosis
Presentation transcript:

Ovarian Tumours Max Brinsmead MBBS PhD November 2014

Incidence 1:10 women will undergo surgery during a lifetime because of suspected ovarian mass 10% turn out to be non ovarian The vast majority in pre menopausal women are benign

Ovarian tumours present as: Pain Mass An incidental finding But the most important thing to determine is whether: It is functional or neoplastic? Benign or malignant?

After the identification of a pelvic adnexal mass evaluation is usually by ultrasound but think… Is there a short history of symptoms? Is this a woman of reproductive age? Cycling spontaneously? Or using progestin-only contraception? A past history of “cysts” Pregnant? Had IVF?

Pathology of Functional Ovarian Tumours: A 2 cm “cyst” occurs every month = mature follicle Haemorrhage from or into a corpus luteum is common Failed follicular rupture can also result in a cyst Endometrioma = ovarian endometriosis

Ultrasound features of a Functional Ovarian Tumour Thin walled Usually no solid components Usually no septa or thin walled septa Usually <6 cm size Usually avascular to colour Doppler Change rapidly And disappear within 6-8w (A role for COC during this period not supported by Cochrane)

Management Guidelines for a Simple Cyst in a Premenopausal Woman Ignore if <30 mm size and asymptomatic Repeat scan after 3m for simple cysts 30 – 50 mm –Further Ix or laparoscopy if they increase in size –Repeat scan in 12m if unchanged and < 70 mm Further Ix and or laparoscopy for cysts >70 mm –Ca 125 –Further imaging (CT or NMR) Laparotomy may be better for suspected dermoid >70 mm

Clinical Features of a Neoplastic Ovarian Tumour: Older women Larger tumours Solid/Cystic or multiple septate Bilateral Fixed, tender or craggy to palpation Ascites present Vascular to colour Doppler Persist or enlarge (4m re evaluation for postmenopausal women) Associated with positive tumour markers – CA125, CA19.9, CEA (AFP,  HCG, LDH)

Differential diagnosis for an Ovarian Tumour: Full bladder Pregnancy Loaded caecum or sigmoid colon Hydrosalpinx Mesenteric cyst Fiboid (subserosal) Pelvic kidney etc Paraovarian cyst

Comprehensive DD of Adnexal Masses

Pathology of Ovarian Neoplasms Germ cell Tumours –Benign cystic = Dermoid (the most common neoplasm of young ♀ – 15% bilateral) –Malignant includes Dysgerminoma (LDH), Teratocarcinoma, Endodermal sinus Ca (AFP), Chorioca (bHCG) Epithelial –Cystadenoma (serous and mucinous) –Cystadenocarcinoma Serous – Mucinous – Endometroid – Clear cell adenoCa Functional –E2 producing (granulosa cell benign or malignant) –Androgen producing (Androblastoma) Secondary Cancers (Stomach, Bowel, Breast etc)

Role of Ca 125 Of most value in the evaluation of adnexal mass in postmenopusal women Too many false positives in premenopausal women –Endometriosis, Adenomyosis, Fibroids & PID Always of concern if >200 Specific only for epithelial tumours –And only 50% sensitive for early stage disease

Staging of Ovarian Cancer: Stage 1A - Confined to one ovary 1B - Ascites or +ve peritoneal cytology Stage 2A - Involves uterus or tubes 2B - Involves other pelvic viscera Stage 3A - Confined to pelvis 3B - to lymph nodes or upper abdominal implants >2cm Stage 4 - Distant metastases

Treatment of Ovarian Cancer: Debulking surgery = TAH + BSO+Omentectomy Chemotherapy Radiotherapy Special cases Children Young woman – no children Advanced disease

Prognosis for ovarian cancer: Overall 30 – 35% but this is because it presents late With modern gynaecological oncology (debaulking + aggressive combination chemotherapy) it should be >50%

Preventing ovarian cancer: Screening- Vaginal exams - Ultrasound & CA125 Have been disappointing – too many false positives Prophylactic Oophorectomy - at hysterectomy (40%) - for genetically predisposed (BRAC carriers) Prophylactic salpingectomy

Any Questions or Comments? Please leave a note on the Welcome Page to this website